Alquil-lysophospholipids and cancer: development of lipid nanoparticles for oral administration and preclinical studies

Current leukemia treatments are generally associated to severe side-effects and relapse is frequent in adults. Edelfosine (ET) is the prototype of a family of antitumor drugs with potent antitumor effects against several cancer types. However, the use of ET in clinic remains limited due to ET side-e...

詳細記述

書誌詳細
主要な著者: Lasa-Saracibar, B. (Beatriz), Blanco-Prieto, M.J. (María José)
フォーマット: info:eu-repo/semantics/doctoralThesis
言語:eng
出版事項: 2016
主題:
オンライン・アクセス:https://hdl.handle.net/10171/40089